24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Exalenz
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:55
Oracle and Broadcom rattle markets as AI trade hits a reality check
18:38
Hub Security to pay $11 million to settle claims over SPAC listing
16:02
Starlink selects Israeli chipmaker Xsight for V3 satellite network
15:40
Breaking electrolysis: Inside the Israeli startup betting on cheap green hydrogen
More stories
Buzz
Most popular
Daily
Weekly
1
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
2
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
3
“Younger people are getting cancer more and more. We have to make kinder medicines.”
4
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
5
After over $390 million in funding, Believer Meats abruptly shuts down
More news
Exalenz
2 stories about Exalenz
Exalenz Bioscience Acquired for $49M
19.02.20
|
Golan Hazani
Israeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
19.02.20
|
Golan Hazani
Tel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source